128 related articles for article (PubMed ID: 25350410)
1. [Persistant perfluorinated compounds cause immunotoxic effects].
Heilmann C; Jensen L; Weihe P; Nielsen F; Knudsen LE; Budtz-Jørgensen E; Mølbak K; Grandjean P
Ugeskr Laeger; 2014 Feb; 176(9A):V09130572. PubMed ID: 25350410
[TBL] [Abstract][Full Text] [Related]
2. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.
Grandjean P; Andersen EW; Budtz-Jørgensen E; Nielsen F; Mølbak K; Weihe P; Heilmann C
JAMA; 2012 Jan; 307(4):391-7. PubMed ID: 22274686
[TBL] [Abstract][Full Text] [Related]
3. Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response.
Abraham K; Mielke H; Fromme H; Völkel W; Menzel J; Peiser M; Zepp F; Willich SN; Weikert C
Arch Toxicol; 2020 Jun; 94(6):2131-2147. PubMed ID: 32227269
[TBL] [Abstract][Full Text] [Related]
4. Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children.
Grandjean P; Budtz-Jørgensen E
Environ Health; 2013 Apr; 12(1):35. PubMed ID: 23597293
[TBL] [Abstract][Full Text] [Related]
5. Structural equation modeling of immunotoxicity associated with exposure to perfluorinated alkylates.
Mogensen UB; Grandjean P; Heilmann C; Nielsen F; Weihe P; Budtz-Jørgensen E
Environ Health; 2015 Jun; 14():47. PubMed ID: 26041029
[TBL] [Abstract][Full Text] [Related]
6. Immunotoxicity of perfluorinated compounds: recent developments.
DeWitt JC; Peden-Adams MM; Keller JM; Germolec DR
Toxicol Pathol; 2012; 40(2):300-11. PubMed ID: 22109712
[TBL] [Abstract][Full Text] [Related]
7. [Perfluorooctane sulfonic acid and perfluorooctanoic acid].
Minoia C; Leoni E; Sottani C; Biamonti G; Signorini S; Imbriani M
G Ital Med Lav Ergon; 2008; 30(4):309-23. PubMed ID: 19344082
[No Abstract] [Full Text] [Related]
8. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.
Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Timmermann A; Budtz-Jørgensen E
J Immunotoxicol; 2017 Dec; 14(1):188-195. PubMed ID: 28805477
[TBL] [Abstract][Full Text] [Related]
9. Perfluorinated Alkyl Substances: Emerging Insights Into Health Risks.
Grandjean P; Clapp R
New Solut; 2015 Aug; 25(2):147-63. PubMed ID: 26084549
[TBL] [Abstract][Full Text] [Related]
10. Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.
Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Budtz-Jørgensen E
Environ Health Perspect; 2017 Jul; 125(7):077018. PubMed ID: 28749778
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of tetanus and diphtheria antibodies in vaccinated Greenlandic children aged 7-12 years exposed to marine pollutants, a cross sectional study.
Timmermann CAG; Pedersen HS; Weihe P; Bjerregaard P; Nielsen F; Heilmann C; Grandjean P
Environ Res; 2022 Jan; 203():111712. PubMed ID: 34343554
[TBL] [Abstract][Full Text] [Related]
12. Perfluorinated compounds and immunotoxicity in children.
Zobel LR; Olsen GW; Butenhoff JL
JAMA; 2012 May; 307(18):1910; author reply 1910-1. PubMed ID: 22570452
[No Abstract] [Full Text] [Related]
13. Perfluorinated compounds: emerging POPs with potential immunotoxicity.
Corsini E; Luebke RW; Germolec DR; DeWitt JC
Toxicol Lett; 2014 Oct; 230(2):263-70. PubMed ID: 24503008
[TBL] [Abstract][Full Text] [Related]
14. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
Trollfors B; Taranger J; Lagergård T; Sundh V
Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717
[TBL] [Abstract][Full Text] [Related]
15. Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper.
Suja F; Pramanik BK; Zain SM
Water Sci Technol; 2009; 60(6):1533-44. PubMed ID: 19759456
[TBL] [Abstract][Full Text] [Related]
16. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.
Melzer D; Rice N; Depledge MH; Henley WE; Galloway TS
Environ Health Perspect; 2010 May; 118(5):686-92. PubMed ID: 20089479
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 years.
Fei C; Olsen J
Environ Health Perspect; 2011 Apr; 119(4):573-8. PubMed ID: 21062688
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.
Looker C; Luster MI; Calafat AM; Johnson VJ; Burleson GR; Burleson FG; Fletcher T
Toxicol Sci; 2014 Mar; 138(1):76-88. PubMed ID: 24284791
[TBL] [Abstract][Full Text] [Related]
19. Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence.
DeWitt JC; Blossom SJ; Schaider LA
J Expo Sci Environ Epidemiol; 2019 Mar; 29(2):148-156. PubMed ID: 30482935
[TBL] [Abstract][Full Text] [Related]
20. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort.
Dalsager L; Christensen N; Husby S; Kyhl H; Nielsen F; Høst A; Grandjean P; Jensen TK
Environ Int; 2016 Nov; 96():58-64. PubMed ID: 27608427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
